As of today, short proposals for the LBG Clinical Research Groups can be submitted via an online platform until 17 November. The new funding programme closes agap in the clinical research field and the translation between basic research and application-oriented development.

Federal Minister for Education, Science and Research Martin Polaschek congratulates: “With this new funding programme, the Ministry, together with LBG, will break new ground and thus enable medical innovations. The funding programme ‘Clinical Research Groups’ closes a funding gap in Austria and is intended both to promote academic clinical research and to give young, clinically active researchers the chance to make a career in health and medical research. We are strengthening the competitiveness of Austria as a clinical research location.”

The selection is made by an international scientific expert committee chaired by Prof. Lieselotte Højgaard, Professor of Medicine and Technology at the University of Copenhagen, Denmark, and Head of the Department of Clinical Physiology, Nuclear Medicine and PET at the Danish Rigshospitalet. The other members are from France, England, Germany and Switzerland. LBG President Prof. Dr Freyja-Maria Smolle-Jüttner: “This independent, top-class committee ensures the highest quality standards. This ambitious programme will contribute significantly to securing the location and future positioning of our country in clinical research, the life sciences and medical development. Just like with the other programmes of the Ludwig Boltzmann Gesellschaft, we will pay special attention to the promotion of young scientists who will carry our country into the future.”

LBG Clinical Research Groups

The CRG is Austria’s first funding programme in the field of non-commercial disease- and patient-oriented (translational), consortium-based clinical research. The programme will also open up new career opportunities for young researchers. A total of 24 million euros is available for a funding period of 8 years.